chrX-136648329-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_000074.3(CD40LG):āc.81A>Gā(p.Leu27=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00055 in 1,203,293 control chromosomes in the GnomAD database, including 5 homozygotes. There are 182 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0029 ( 3 hom., 94 hem., cov: 22)
Exomes š: 0.00031 ( 2 hom. 88 hem. )
Consequence
CD40LG
NM_000074.3 synonymous
NM_000074.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.611
Genes affected
CD40LG (HGNC:11935): (CD40 ligand) The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant X-136648329-A-G is Benign according to our data. Variant chrX-136648329-A-G is described in ClinVar as [Benign]. Clinvar id is 530673.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.611 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00292 (326/111766) while in subpopulation AFR AF= 0.0102 (313/30790). AF 95% confidence interval is 0.00924. There are 3 homozygotes in gnomad4. There are 94 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 3 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CD40LG | NM_000074.3 | c.81A>G | p.Leu27= | synonymous_variant | 1/5 | ENST00000370629.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CD40LG | ENST00000370629.7 | c.81A>G | p.Leu27= | synonymous_variant | 1/5 | 1 | NM_000074.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00294 AC: 328AN: 111709Hom.: 3 Cov.: 22 AF XY: 0.00280 AC XY: 95AN XY: 33913
GnomAD3 genomes
AF:
AC:
328
AN:
111709
Hom.:
Cov.:
22
AF XY:
AC XY:
95
AN XY:
33913
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000830 AC: 152AN: 183111Hom.: 0 AF XY: 0.000547 AC XY: 37AN XY: 67689
GnomAD3 exomes
AF:
AC:
152
AN:
183111
Hom.:
AF XY:
AC XY:
37
AN XY:
67689
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000308 AC: 336AN: 1091527Hom.: 2 Cov.: 28 AF XY: 0.000246 AC XY: 88AN XY: 357175
GnomAD4 exome
AF:
AC:
336
AN:
1091527
Hom.:
Cov.:
28
AF XY:
AC XY:
88
AN XY:
357175
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00292 AC: 326AN: 111766Hom.: 3 Cov.: 22 AF XY: 0.00277 AC XY: 94AN XY: 33980
GnomAD4 genome
AF:
AC:
326
AN:
111766
Hom.:
Cov.:
22
AF XY:
AC XY:
94
AN XY:
33980
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hyper-IgM syndrome type 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at